Inactive Instrument
BiVictriX Therapeutics plc Stock
Stocks
BVX
GB00BNXH3K91
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +17.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
CEO | Chief Executive Officer | 39 | 2015-12-31 |
Adrian Howd
DFI | Director of Finance/CFO | 54 | 2023-10-02 |
Alison Halsall
SEC | Corporate Secretary | - | 2023-10-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Kauffman
CHM | Chairman | 62 | 2023-01-05 |
William Paris
BRD | Director/Board Member | 75 | 2021-09-21 |
Susan Lowther
BRD | Director/Board Member | 67 | 2021-09-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/2/24 | Sell | Director | 20,000 | 0.0242% | ||
| 9/2/24 | Buy | Director | 20,000 | 0.0242% | ||
| 8/13/24 | Free | Executive/Senior Manager | 320,000 | 0.3878% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +17.65% | +33.33% | - | - | 10.49M | |
| +1.07% | -4.73% | -3.96% | +11.63% | 46.35B | |
| +0.25% | +5.61% | +404.21% | +606.87% | 40.13B | |
| -0.27% | +2.67% | +10.54% | +65.01% | 36.33B | |
| +0.35% | -1.16% | +7.11% | -8.85% | 34.6B | |
| +3.14% | +1.02% | +3.72% | +34.86% | 26.77B | |
| +0.47% | -2.29% | - | - | 16.66B | |
| -0.73% | +11.80% | +37.49% | +145.18% | 16.91B | |
| +0.42% | -4.46% | +4.80% | +8.67% | 13.05B | |
| -2.68% | -2.49% | -1.27% | -32.60% | 13.05B | |
| Average | +1.97% | +1.02% | +57.83% | +103.85% | 27.09B | |
| Weighted average by Cap. | +0.46% | +0.77% | +76.79% | +132.15% |
Employees
15
